All In Biotech

Drug Trial Radar · NCT05561387

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

A Phase III Randomized Trial for Newly Diagnosed Multiple Myeloma (NDMM) Patients Considered Frail or in a Subset of "Intermediate Fit" Comparing Upfront Three-Drug Induction Regimens Followed by Double or Single-Agent Maintenance

Last checked: Nov 19, 2026Latest source record: Jun 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 510 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

510

Planned (sponsor's estimate)

Start

Oct 12, 2023

Primary completion

May 30, 2031

Study completion May 30, 2031

Sponsor

Lead sponsor
SWOG Cancer Research NetworkResearch network
Sponsor type
Research network
Collaborators
National Cancer Institute (NCI)
First posted
Sep 30, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This phase III trial compares three-drug induction regimens followed by double-or single-drug maintenance therapy for the treatment of newly diagnosed multiple myeloma in patients who are not receiving a stem cell transplant and are considered frail or intermediate-fit based on age, comorbidities, and functional status. Treatment for multiple myeloma includes initial treatment (induction) which is the first treatment a patient receives for cancer followed by ongoing treatment (maintenance) which is given after initial treatment to help keep the cancer from coming back. There are three combinations of four different drugs being studied. Bortezomib is one of the drugs that may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Lenalidomide works by helping bone marrow to produce normal blood cells and killing cancer cells. Anti-inflammatory drugs, such as dexamethasone, lower the body's immune response and are used with other drugs in the treatment of some types of cancer. Daratumumab and hyaluronidase-fihj is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Patients receive 1 of 3 combinations of these drugs for treatment to determine which combination of study drugs works better to shrink and control multiple myeloma.

Conditions

  • Plasma Cell Myeloma

Interventions

  • BortezomibDrug

    Given SC

  • Daratumumab and Hyaluronidase-fihjDrug

    Given SC

  • DexamethasoneDrug

    Given PO

  • LenalidomideDrug

    Given PO

  • Quality-of-Life AssessmentOther

    Ancillary studies

  • Questionnaire AdministrationOther

    Ancillary studies

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression free survival (PFS) of Arm 1 versus (vs.) Arm 2Time frame: From date of randomization to date of first documentation of progression or symptomatic deterioration, or death due to any cause, or assessed up to 10 years
  2. Overall survival (OS) of Arm 1 vs. Arm 3Time frame: From date of randomization to date of death due to any cause, or assessed up to 10 years

Locations

397 sites in 1 country. Site status is shown where the registry gives one.

  • Anchorage Associates in Radiation Medicine

    Anchorage, Alaska · Recruiting

  • Anchorage Radiation Therapy Center

    Anchorage, Alaska · Recruiting

  • Alaska Breast Care and Surgery LLC

    Anchorage, Alaska · Recruiting

  • Alaska Oncology and Hematology LLC

    Anchorage, Alaska · Recruiting

  • Alaska Women's Cancer Care

    Anchorage, Alaska · Recruiting

  • Anchorage Oncology Centre

    Anchorage, Alaska · Recruiting

  • Katmai Oncology Group

    Anchorage, Alaska · Recruiting

  • Providence Alaska Medical Center

    Anchorage, Alaska · Recruiting

  • Cancer Center at Saint Joseph's

    Phoenix, Arizona · Recruiting

  • Mercy Hospital Fort Smith

    Fort Smith, Arkansas · Recruiting

  • CARTI Cancer Center

    Little Rock, Arkansas · Recruiting

  • John L McClellan Memorial Veterans Hospital

    Little Rock, Arkansas · Suspended

  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas · Recruiting

  • Mission Hope Medical Oncology - Arroyo Grande

    Arroyo Grande, California · Recruiting

  • Providence Saint Joseph Medical Center/Disney Family Cancer Center

    Burbank, California · Recruiting

  • Marshall Cancer Center

    Cameron Park, California · Recruiting

  • Mercy Cancer Center - Carmichael

    Carmichael, California · Recruiting

  • Mercy San Juan Medical Center

    Carmichael, California · Recruiting

  • Mercy Cancer Center - Elk Grove

    Elk Grove, California · Recruiting

  • Fremont - Rideout Cancer Center

    Marysville, California · Recruiting

  • Mercy UC Davis Cancer Center

    Merced, California · Recruiting

  • Providence Queen of The Valley

    Napa, California · Recruiting

  • Mercy Cancer Center - Rocklin

    Rocklin, California · Recruiting

  • Mercy Cancer Center - Sacramento

    Sacramento, California · Recruiting

  • University of California Davis Comprehensive Cancer Center

    Sacramento, California · Recruiting

  • Pacific Central Coast Health Center-San Luis Obispo

    San Luis Obispo, California · Recruiting

  • Mission Hope Medical Oncology - Santa Maria

    Santa Maria, California · Recruiting

  • Providence Medical Foundation - Santa Rosa

    Santa Rosa, California · Recruiting

  • Providence Santa Rosa Memorial Hospital

    Santa Rosa, California · Recruiting

  • Gene Upshaw Memorial Tahoe Forest Cancer Center

    Truckee, California · Recruiting

  • Woodland Memorial Hospital

    Woodland, California · Recruiting

  • Rocky Mountain Regional VA Medical Center

    Aurora, Colorado · Recruiting

  • Penrose-Saint Francis Healthcare

    Colorado Springs, Colorado · Recruiting

  • Rocky Mountain Cancer Centers-Penrose

    Colorado Springs, Colorado · Recruiting

  • Saint Francis Cancer Center

    Colorado Springs, Colorado · Recruiting

  • Porter Adventist Hospital

    Denver, Colorado · Suspended

  • Mercy Medical Center

    Durango, Colorado · Recruiting

  • Southwest Oncology PC

    Durango, Colorado · Recruiting

  • Saint Anthony Hospital

    Lakewood, Colorado · Recruiting

  • Littleton Adventist Hospital

    Littleton, Colorado · Suspended

Showing 40 of 397 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.